Neuronex gets US FDA GLP certification

Published: 2010-02-02 06:57:00

Updated: 2010-02-02 06:57:00

Local biopharmaceutical firm Neuronex Co. has recently passed the GLP (Good Laboratory Practice) skin irritation test of the US Food and Drug Administration over its new topical treatment for Raynaud's disease, according to a company spokesperson.

Neuronex has developed a novel, peripheral blo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK